FIELD: medicine.
SUBSTANCE: invention concerns medical equipment, namely to endoluminal prostheses, such as a coronary stent. The stent for implantation at least partially, in a blood vessel in contact to a blood vessel wall, contains at least one released medical agent. The released medical agent contains melatonin or a medical product received from the melatonin. The medical agent is applied on the surface of a stent which does not have coverings.
EFFECT: invention provides prevention of an inflammation caused by a trauma, caused at the expense of stent implantation; the prevention neointimal proliferation of a tissue and growing in a tissue; controlled remission completely a biocompatible medical product in a current of several weeks.
6 cl, 1 tbl
